GeriDerm

A platform to bring together healthcare professionals, share research and news updates, to improve the care of skin diseases in older adults. #geriderm

[GeriDerm @GeriDerm]

Really important work about telederm in older adults.

What have your your challenges/successes?

https://t.co/U9GOtUjbA8$

[GeriDerm @GeriDerm]

**GeriDerm ERG 1 hour Meeting**

Join us this Tuesday 10/5

9amPDT/12pm EST

Updates on GeriDerm research and clinical practice as well as initial task force development. If interested, please join!

[GeriDerm @GeriDerm]

Thank you for highlighting geriatric dermatology.

https://t.co/42drVn7MeR

[GeriDerm @GeriDerm]

Would you use gabapentinoids or antihistamines for itch in older adults?

Spoiler alert: it’s not antihistamines

Excellent work by @UofUMedicine student and GeriDerm Student lead Shreya Sreekantaswamy.

[Dermatology and Therapy @DermatolTher]

Gabapentin and pregabalin are efficacious and safe options for the treatment of multifactorial pruritus in older adults. @DanielButlerMD and @SSreekantaswamy provide context to the nuances of prescribing and advocates for the inclusion of these medications in this population.

[GeriDerm @GeriDerm]

How do dermatologists address adherence in older patients?

This article gives practical tips to meet the needs of older patients beyond just diagnosis and treatment.

Ex: Have you ever recommended a patient cut the end of their topical cream tube?

https://t.co/RRUzTm4YKr

[GeriDerm @GeriDerm]

Critical work for the Geri Derm community looking at antihistamines in older adults.

This work looks at risks, benefits and gives practical tips. @JAADjournals @DanielButlerMD @linos_eleni

https://t.co/Joo7aZu0Fx

[Aaron Drucker @aaron_drucker]

We found atopic dermatitis cannot be accurately identified in Ontario administrative data, but can in EMR data. EMR case definitions can now be linked with admin data for health services research. Thanks to @PSIFoundation @CdnDermFdn @CIHR_IRSC for funding!

[GeriDerm @GeriDerm]

Grovers disease along w pruritus may be most quintessential Geri Derm conditions.

What do you all think?

#dermtwitter
#medtwitter

[Daniel Butler MD @DanielButlerMD]

Really fun to write this article: https://t.co/d3PYAwgk4X

Grover disease is a microcosm of geriatric dermatology @GeriDerm : we kinda know it when we see it but just starting to understand underlying details of pathophys and treatment.

Hope this continues the discussion.

[GeriDerm @GeriDerm]

Hoping for continued geriatric dermatology features in @TheDermEditor !

[The Dermatologist @TheDermEditor]

Our December issue is now live online, featuring topics such as geriatric dermatology, androgenetic alopecia, IBD and psoriasis, and the 2021 E/M coding changes! Read the full issue at https://t.co/4VNbWxIJIW #dermtwitter

[Daniel Butler MD @DanielButlerMD]

Thank you @TheDermEditor for featuring our work in developing Geri Dermatology @GeriDerm

Facts:
-Aging=inevitable
-Derms see loads of older adults
-Older patients often challenge the derm scientific, educational, and system infrastructure
-Huge opportunity for growth

[GeriDerm @GeriDerm]

Excellent program for scientists interested in aging!

[Clin-STAR Coordinating Center @ClinSTARCC]

Join the NIA-funded Clin-STAR database today! Complete this brief questionnaire by December 22 to secure your spot in this national, high-impact community of clinician-scientists in aging research: https://t.co/kUq2AAdQ24

[ACEP Geriatric Sect @GeriatricEDNews]

@ClinSTARCC On #CLINSTAR2O day 2 @UnaMakris describes approaches to increase your exposure to aging researchers & influencers in and outside your specialty! @ACSTrauma @Geri_Nephrology @GeriDerm @GeriPulm @AmerGeriatrics @AGEM_SAEM @Alzheimers_NIH @ACRheum @SAEMonline https://t.co/UkajtzsKB4

[Roxana Daneshjou MD/PhD @RoxanaDaneshjou]

Hi #DermTwitter and #MedTwitter, check out this new society dedicated to geriatric dermatology!

[GeriDerm @GeriDerm]

Our group is so proud to get this up and running.

Please let us know what challenges you all see in older patients w cutaneous disease.

[Daniel Butler MD @DanielButlerMD]

Announcing:
The Geriatric Dermatology Society

https://t.co/8iUP580sAo

Thanks to leadership from medical student lead Shreya Sreekantaswamy from @UofUMedicine

We hope this serves as a collaborative platform for research, clinical, educational advancement. #dermtwitter

[GeriDerm @GeriDerm]

“Get rid of the idea that general dermatology is the same as geriatric dermatology”

[GeriDerm @GeriDerm]

Ageism in dermatology

https://t.co/pDmDH2I5eJ

[GeriDerm @GeriDerm]

Ageism in dermatology

https://t.co/pDmDH2I5eJ

[GeriDerm @GeriDerm]

We must continue to advocate for older patients in dermatology. The responsibility is on the field.

The more momentum we build, the more we can meet the needs of our aging population.
https://t.co/6JVyICHp0Y

[Daniel Butler MD @DanielButlerMD]

This is a massive issue. We’re blind treating these patients because they are not included. Leave providers and patients w anxiety treating because there’s not enough data. Often results in undertreatment.

It’s dermatology‘s job to advocate, prioritize and include older adults

[GeriDerm @GeriDerm]

Please follow this link (https://t.co/ABzP7g7v4G) to participate in a 15-minute survey, with shorter monthly follow-up surveys.

[GeriDerm @GeriDerm]

Did any older patients delay treatment for BCC and SCC?

Mackenzie Wehner at MD Anderson Cancer Center is conducting an IRB-approved study on COVID-related delays in skin cancer treatments to understand patient experiences (e.g. symptoms, emotions, changes to their tumor).

[GeriDerm @GeriDerm]

Information to send directly to patients:
Researchers at MD Anderson are conducting a study to understand the experiences of people who have been diagnosed with Basal Cell Carcinoma (BCC) or Squamous Cell Carcinoma (SCC) and have had their treatment delayed due to COVID-19.